Level B· Emerging clinical evidence with positive signalsClinical TrialEurope PMC

Translation of Human-Induced Pluripotent Stem Cells: From Clinical Trial in a Dish to Precision Medicine

Sayed N., Liu C., Wu JC.

Clinical Trial, published in J Am Coll Cardiol (2016) — summary generated from the PubMed abstract.

Open my reading list
Level B· Emerging clinical evidence with positive signalsEvidence level of this study

Several human studies show positive signals, while research methods and sample sizes continue to develop.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Clinical Trial
Journal
J Am Coll Cardiol (2016)
Reported sample size
—
Source database
Europe PMC
PMID
27151349
PMCID
PMC5086255
DOI
10.1016/j.jacc.2016.01.083
Citations
209

Abstract (original English)

The prospect of changing the plasticity of terminally differentiated cells toward pluripotency has completely altered the outlook for biomedical research. Human-induced pluripotent stem cells (iPSCs) provide a new source of therapeutic cells free from the ethical issues or immune barriers of human embryonic stem cells. iPSCs also confer considerable advantages over conventional methods of studying human diseases. Since its advent, iPSC technology has expanded with 3 major applications: disease modeling, regenerative therapy, and drug discovery. Here we discuss, in a comprehensive manner, the recent advances in iPSC technology in relation to basic, clinical, and population health.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Several human studies show positive signals, while research methods and sample sizes continue to develop.

How we grade evidence
HumansCardiovascular DiseasesTissue EngineeringPharmacogeneticsRegenerative MedicineModels, BiologicalCell TransdifferentiationDrug DiscoveryInduced Pluripotent Stem CellsPrecision Medicine

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.